WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Increase (Decrease) in Accounts Receivable
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Increase (Decrease) in Accounts Receivable of -$4.38 million for the 9-month period ending 2012-09-30, per its 10-Q/A filed 2012-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2012-12-11
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accounts receivable for the quarter ending 2012-09-30 was $67.05K, a 98.10% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accounts receivable for the quarter ending 2012-06-30 was -$1.54M, a 166.98% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accounts receivable for the quarter ending 2012-03-31 was -$2.91M.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accounts receivable for the quarter ending 2011-12-31 was -$931.19K.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accounts receivable for fiscal 2011 was $4.77M, a 647.82% increase from fiscal 2010.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accounts receivable for fiscal 2010 was $638.02K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2012-09-30 | $67.05K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11 | -$1.48M derived: sum of 2 quarters · filed 2012-12-11 | -$4.38M 10-Q/A · filed 2012-12-11 | -$5.32M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-06-30 | -$1.54M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30 | -$4.45M 10-Q/A · filed 2012-08-30 | -$5.38M derived: sum of 3 quarters · filed 2012-08-30 | -$1.85M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-03-31 | -$2.91M 10-Q · filed 2012-05-15 | -$3.84M derived: sum of 2 quarters · filed 2012-05-15 | -$309.66K derived: sum of 3 quarters · filed 2012-12-11 | $1.99M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-12-31 | -$931.19K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $2.60M derived: sum of 2 quarters · filed 2012-12-11 | $4.90M derived: sum of 3 quarters · filed 2012-12-11 | $4.77M 10-K · filed 2012-03-30 |
| 2011-09-30 | $3.53M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11 | $5.83M derived: sum of 2 quarters · filed 2012-12-11 | $5.70M 10-Q/A · filed 2012-12-11 | $5.43M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-06-30 | $2.30M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30 | $2.17M 10-Q/A · filed 2012-08-30 | $1.90M derived: sum of 3 quarters · filed 2012-08-30 | |
| 2011-03-31 | -$131.15K 10-Q · filed 2012-05-15 | -$403.80K derived: sum of 2 quarters · filed 2012-05-15 | ||
| 2010-12-31 | -$272.65K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $638.02K 10-K · filed 2012-03-30 | ||
| 2010-09-30 | $910.68K 10-Q · filed 2011-11-21 |